Fig. 1From: Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in SwedenDecision-tree model structure. First-level decision nodes represent the treatment comparison. Second-level decision nodes represent the IA/mucormycosis pathogen split. Third-level decision nodes are associated with second-line treatment options. IA, invasive aspergillosis; L-AmB, liposomal amphotericin-BBack to article page